123 related articles for article (PubMed ID: 15694112)
1. Increased levels of glucocorticoid receptors and enhanced glucocorticoid receptor auto-regulation after hydrocortisone challenge in B-lymphoblastoids from patients with affective disorders.
Henning U; Krieger K; Loeffler S; Rivas F; Orozco G; de Castro MG; Rietschel M; Noethen MM; Klimke A
Psychoneuroendocrinology; 2005 May; 30(4):325-32. PubMed ID: 15694112
[TBL] [Abstract][Full Text] [Related]
2. Reduced Glucocorticoid Receptor alpha Expression in Mood Disorder Patients and First-Degree Relatives.
Matsubara T; Funato H; Kobayashi A; Nobumoto M; Watanabe Y
Biol Psychiatry; 2006 Apr; 59(8):689-95. PubMed ID: 16458268
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation status of glucocorticoid receptor, heat shock protein 70, cytochrome c and Bax in lymphocytes of euthymic, depressed and manic bipolar patients.
Bei E; Salpeas V; Pappa D; Anagnostara C; Alevizos V; Moutsatsou P
Psychoneuroendocrinology; 2009 Sep; 34(8):1162-75. PubMed ID: 19359101
[TBL] [Abstract][Full Text] [Related]
4. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
Papadopoulos A; Ebrecht M; Roberts AD; Poon L; Rohleder N; Cleare AJ
J Affect Disord; 2009 Jan; 112(1-3):289-94. PubMed ID: 18573538
[TBL] [Abstract][Full Text] [Related]
6. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects.
Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS
Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588
[TBL] [Abstract][Full Text] [Related]
7. Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients.
Spiliotaki M; Salpeas V; Malitas P; Alevizos V; Moutsatsou P
Psychoneuroendocrinology; 2006 Jul; 31(6):748-60. PubMed ID: 16621324
[TBL] [Abstract][Full Text] [Related]
8. Altered sirtuin deacetylase gene expression in patients with a mood disorder.
Abe N; Uchida S; Otsuki K; Hobara T; Yamagata H; Higuchi F; Shibata T; Watanabe Y
J Psychiatr Res; 2011 Aug; 45(8):1106-12. PubMed ID: 21349544
[TBL] [Abstract][Full Text] [Related]
9. Circulating lymphocyte subsets, natural killer cell cytotoxicity, and components of hypothalamic-pituitary-adrenal axis in Croatian war veterans with posttraumatic stress disorder: cross-sectional study.
Vidović A; Vilibić M; Sabioncello A; Gotovac K; Rabatić S; Folnegović-Smalc V; Dekaris D
Croat Med J; 2007 Apr; 48(2):198-206. PubMed ID: 17436384
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid receptor number and cortisol excretion in mood, anxiety, and psychotic disorders.
Yehuda R; Boisoneau D; Mason JW; Giller EL
Biol Psychiatry; 1993 Jul 1-15; 34(1-2):18-25. PubMed ID: 8373936
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function.
Watson S; Thompson JM; Ritchie JC; Nicol Ferrier I; Young AH
Bipolar Disord; 2006 Feb; 8(1):85-90. PubMed ID: 16411985
[TBL] [Abstract][Full Text] [Related]
12. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
[TBL] [Abstract][Full Text] [Related]
13. Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.
Gallagher P; Watson S; Elizabeth Dye C; Young AH; Nicol Ferrier I
J Psychiatr Res; 2008 Oct; 42(12):1037-41. PubMed ID: 18255098
[TBL] [Abstract][Full Text] [Related]
14. The stress system in the human brain in depression and neurodegeneration.
Swaab DF; Bao AM; Lucassen PJ
Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
[TBL] [Abstract][Full Text] [Related]
15. Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder.
Grassi-Oliveira R; Brietzke E; Pezzi JC; Lopes RP; Teixeira AL; Bauer ME
Psychiatry Clin Neurosci; 2009 Apr; 63(2):202-8. PubMed ID: 19175760
[TBL] [Abstract][Full Text] [Related]
16. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders.
Su TP; Zhang L; Chung MY; Chen YS; Bi YM; Chou YH; Barker JL; Barrett JE; Maric D; Li XX; Li H; Webster MJ; Benedek D; Carlton JR; Ursano R
J Psychiatr Res; 2009 Sep; 43(13):1078-85. PubMed ID: 19380152
[TBL] [Abstract][Full Text] [Related]
17. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
[TBL] [Abstract][Full Text] [Related]
18. Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice.
Howell MP; Muglia LJ
Front Neuroendocrinol; 2006 Sep; 27(3):275-84. PubMed ID: 16814372
[TBL] [Abstract][Full Text] [Related]
19. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
Peña S; Baccichet E; Urbina M; Carreira I; Lima L
Int Immunopharmacol; 2005 Jun; 5(6):1069-76. PubMed ID: 15829422
[TBL] [Abstract][Full Text] [Related]
20. Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders.
Watson S; Gallagher P; Ferrier IN; Young AH
J Psychiatr Res; 2006 Jun; 40(4):353-9. PubMed ID: 16165159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
